Sorafenib for Advanced Hepatocellular Carcinoma (HCC): Impact of Rationing in the United Kingdom.

Journal of Clinical Oncology - United States
doi 10.1200/jco.2010.28.15_suppl.e14516
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society of Clinical Oncology (ASCO)

Related search

Can We Use Sorafenib Targeted Therapy for Advanced Hepatocellular Carcinoma (HCC) Child Pugh B

HPB
HepatologyGastroenterology
2016English

Nivolumab in Advanced Hepatocellular Carcinoma: Sorafenib-Experienced Asian Cohort Analysis

Journal of Hepatology
Hepatology
2019English

Sorafenib in Hepatocellular Carcinoma

Clinical Medicine. Therapeutics
2009English

Transcatheter Arterial Chemoembolization After Stopping Sorafenib Therapy for Advanced Hepatocellular Carcinoma

PLoS ONE
Multidisciplinary
2017English

A Clinical Phase II Study of Sorafenib in Advanced Hepatocellular Carcinoma

Anaplastology
2012English

Attenuation of Liver Stiffness in Sorafenib-Treated Patients With Advanced Hepatocellular Carcinoma

Hepatoma Research
2017English

Sorafenib for the Treatment of Unresectable Hepatocellular Carcinoma

Biologics: Targets and Therapy
OncologyImmunologyGastroenterologyPharmacologyRheumatologyAllergy
2008English

Sorafenib Alone Versus Sorafenib Combined With Transarterial Chemoembolization for Advanced-Stage Hepatocellular Carcinoma: Results of Propensity Score Analyses

Radiology
Nuclear MedicineRadiologyImaging
2013English

MRI in Detection of Hepatocellular Carcinoma (HCC)

Cancer Imaging
Nuclear MedicineRadiologyUltrasound TechnologyOncologyRadiologicalImagingMedicine
2005English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy